Market Cap 1.22B
Revenue (ttm) 0.00
Net Income (ttm) -53.59M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 223,800
Avg Vol 186,980
Day's Range N/A - N/A
Shares Out 67.30M
Stochastic %K 30%
Beta 1.79
Analysts Sell
Price Target $22.00

Company Profile

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; CellFX nsPFA Percutaneous Electrode system for soft tissue ablation in surgical setting; CellFX nsPFA Cardiac Clamp designed for use in surgical treatment of atrial fibrillation (AF); CellFX nsPFA 360° Cardiac Catheter designed to provide a circumferential, or circular, ablation in a single treatment cyc...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 510 906 4600
Address:
601 Brickell Key Drive, Suite 1080, Miami, United States
TruthBroker2
TruthBroker2 Oct. 27 at 12:18 PM
$SMMT $PLSE TEAM GENIUS 24
0 · Reply
TruthBroker2
TruthBroker2 Oct. 24 at 1:55 AM
0 · Reply
TruthBroker2
TruthBroker2 Oct. 21 at 1:28 PM
0 · Reply
TruthBroker2
TruthBroker2 Oct. 13 at 3:07 PM
0 · Reply
ZacksResearch
ZacksResearch Oct. 13 at 12:31 PM
$PLSE's cardiac innovation — a potential shift for AF treatment? 💥 The nPulse Cardiac Surgical System shows 94% success in pulmonary vein isolation with no severe complications in the high-dose group, positioning it as a disruptive option against traditional thermal methods. 🔍 Discover the full clinical insights here 👉 https://www.zacks.com/stock/news/2767188/pulse-biosciences-unveils-promising-first-in-human-data-for-npulse?cid=sm-stocktwits-2-2767188-body-15676&ADID=SYND_STOCKTWITS_TWEET_2_2767188_BODY_15676
0 · Reply
ZacksResearch
ZacksResearch Oct. 13 at 11:31 AM
Breakthrough alert: $PLSE just dropped first-in-human data for its nPulse system 🚀 Early results show safety, rapid procedure times, and strong potential for durable AF treatment — a major milestone for its cardiac tech platform. See the full data and what it means for PLSE’s future here 👉 https://www.zacks.com/stock/news/2767188/pulse-biosciences-unveils-promising-first-in-human-data-for-npulse?cid=sm-stocktwits-2-2767188-teaser-15675&ADID=SYND_STOCKTWITS_TWEET_2_2767188_TEASER_15675
0 · Reply
TruthBroker2
TruthBroker2 Oct. 10 at 1:16 PM
0 · Reply
OpenOutcrier
OpenOutcrier Oct. 10 at 12:50 PM
$PLSE (+3.9% pre) Pulse Biosciences Announces Presentation of Late-Breaking Data From the nPulse™ Cardiac Surgical System First-in-Human Feasibility Study at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting https://ooc.bz/l/80079
0 · Reply
DARKP00L
DARKP00L Oct. 10 at 11:04 AM
$PLSE 07:02 on Oct. 10 2025 Pulse Biosciences Announces Late-Breaking Clinical Study Results From nPulse Cardiac Surgical System First-In-Human Feasibility Study At 39th European Association For Cardio-Thoracic Surgery Annual Meeting #tradeideas
1 · Reply
TruthBroker2
TruthBroker2 Oct. 9 at 1:18 PM
0 · Reply
Latest News on PLSE
Pulse Biosciences, Inc. (PLSE) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 9:06 PM EDT - 2 months ago

Pulse Biosciences, Inc. (PLSE) Q2 2025 Earnings Call Transcript


Pulse Biosciences, Inc. (PLSE) Q1 2025 Earnings Call Transcript

May 10, 2025, 11:02 PM EDT - 6 months ago

Pulse Biosciences, Inc. (PLSE) Q1 2025 Earnings Call Transcript


Pulse Biosciences, Inc. (PLSE) Q4 2024 Earnings Call Transcript

Mar 27, 2025, 7:46 PM EDT - 7 months ago

Pulse Biosciences, Inc. (PLSE) Q4 2024 Earnings Call Transcript


Pulse Biosciences, Inc. Announces Planned Redemption of Warrants

Dec 23, 2024, 4:30 PM EST - 11 months ago

Pulse Biosciences, Inc. Announces Planned Redemption of Warrants


TruthBroker2
TruthBroker2 Oct. 27 at 12:18 PM
$SMMT $PLSE TEAM GENIUS 24
0 · Reply
TruthBroker2
TruthBroker2 Oct. 24 at 1:55 AM
0 · Reply
TruthBroker2
TruthBroker2 Oct. 21 at 1:28 PM
0 · Reply
TruthBroker2
TruthBroker2 Oct. 13 at 3:07 PM
0 · Reply
ZacksResearch
ZacksResearch Oct. 13 at 12:31 PM
$PLSE's cardiac innovation — a potential shift for AF treatment? 💥 The nPulse Cardiac Surgical System shows 94% success in pulmonary vein isolation with no severe complications in the high-dose group, positioning it as a disruptive option against traditional thermal methods. 🔍 Discover the full clinical insights here 👉 https://www.zacks.com/stock/news/2767188/pulse-biosciences-unveils-promising-first-in-human-data-for-npulse?cid=sm-stocktwits-2-2767188-body-15676&ADID=SYND_STOCKTWITS_TWEET_2_2767188_BODY_15676
0 · Reply
ZacksResearch
ZacksResearch Oct. 13 at 11:31 AM
Breakthrough alert: $PLSE just dropped first-in-human data for its nPulse system 🚀 Early results show safety, rapid procedure times, and strong potential for durable AF treatment — a major milestone for its cardiac tech platform. See the full data and what it means for PLSE’s future here 👉 https://www.zacks.com/stock/news/2767188/pulse-biosciences-unveils-promising-first-in-human-data-for-npulse?cid=sm-stocktwits-2-2767188-teaser-15675&ADID=SYND_STOCKTWITS_TWEET_2_2767188_TEASER_15675
0 · Reply
TruthBroker2
TruthBroker2 Oct. 10 at 1:16 PM
0 · Reply
OpenOutcrier
OpenOutcrier Oct. 10 at 12:50 PM
$PLSE (+3.9% pre) Pulse Biosciences Announces Presentation of Late-Breaking Data From the nPulse™ Cardiac Surgical System First-in-Human Feasibility Study at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting https://ooc.bz/l/80079
0 · Reply
DARKP00L
DARKP00L Oct. 10 at 11:04 AM
$PLSE 07:02 on Oct. 10 2025 Pulse Biosciences Announces Late-Breaking Clinical Study Results From nPulse Cardiac Surgical System First-In-Human Feasibility Study At 39th European Association For Cardio-Thoracic Surgery Annual Meeting #tradeideas
1 · Reply
TruthBroker2
TruthBroker2 Oct. 9 at 1:18 PM
0 · Reply
TruthBroker2
TruthBroker2 Oct. 8 at 12:31 PM
0 · Reply
liloleme4
liloleme4 Oct. 3 at 3:29 PM
$PLSE Up nicely today and can't find a word about it, even on ST... Perhaps I've blocked too many bots?
0 · Reply
TruthBroker2
TruthBroker2 Oct. 3 at 12:59 PM
$PLSE Be lookin Good
0 · Reply
Doozio
Doozio Oct. 3 at 11:04 AM
It was always 🐒🍌🧠⏰♾️ wen da 🐑 wud get a $PLSE as the GRRR’s turned to MLYS then became BILI’s as its $LIVE in this $GME
0 · Reply
TruthBroker2
TruthBroker2 Oct. 2 at 1:30 PM
0 · Reply
TruthBroker2
TruthBroker2 Oct. 1 at 3:19 PM
0 · Reply
TruthBroker2
TruthBroker2 Sep. 29 at 11:18 AM
0 · Reply
TruthBroker2
TruthBroker2 Sep. 26 at 1:36 PM
0 · Reply
Elean001
Elean001 Sep. 25 at 11:18 PM
0 · Reply
TruthBroker2
TruthBroker2 Sep. 25 at 11:25 AM
0 · Reply
TruthBroker2
TruthBroker2 Sep. 24 at 2:05 PM
0 · Reply
LeisureSuitLarry
LeisureSuitLarry Sep. 22 at 10:27 PM
0 · Reply